| scholarly article | Q13442814 |
| P2093 | author name string | Jinsong Liu | |
| Nigel Walker | |||
| Sheree Johnstone | |||
| Xiaoshan Min | |||
| Zhulun Wang | |||
| Songzhu An | |||
| Jessica Dai | |||
| Shou-Hua Xiao | |||
| Haoda Xu | |||
| David Meininger | |||
| Stephen Thibault | |||
| William Romanow | |||
| P2860 | cites work | Phasercrystallographic software | Q27860930 |
| P433 | issue | 5 | |
| P304 | page(s) | 798-809 | |
| P577 | publication date | 2013-05-07 | |
| P1433 | published in | Structure | Q15709970 |
| P1476 | title | Molecular basis of sphingosine kinase 1 substrate recognition and catalysis | |
| P478 | volume | 21 |
| Q41661043 | "Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer. |
| Q33825060 | A real-time high-throughput fluorescence assay for sphingosine kinases |
| Q35580940 | A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties |
| Q45065681 | An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors. |
| Q50078186 | An intrinsic lipid-binding interface controls sphingosine kinase 1 function |
| Q39959298 | Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations |
| Q34505523 | Coupling between endocytosis and sphingosine kinase 1 recruitment. |
| Q41680076 | Crystal Structure of Sphingosine Kinase 1 with PF-543 |
| Q47146575 | Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents. |
| Q57820942 | Diacylglycerol kinases: Relationship to other lipid kinases |
| Q99241043 | Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer |
| Q30366282 | Drugging sphingosine kinases. |
| Q26863646 | Evolving concepts in cancer therapy through targeting sphingolipid metabolism |
| Q36407214 | Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration. |
| Q57169965 | Expression and purification of human diacylglycerol kinase α from baculovirus-infected insect cells for structural studies |
| Q90456543 | Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors |
| Q61796801 | Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift |
| Q92191163 | In Silico Characterization of Structural Distinctions between Isoforms of Human and Mouse Sphingosine Kinases for Accelerating Drug Discovery |
| Q41828412 | Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II. |
| Q26851470 | Leukocyte driven-decidual angiogenesis in early pregnancy |
| Q28551358 | Mouse Sphingosine Kinase 1a Is Negatively Regulated through Conventional PKC-Dependent Phosphorylation at S373 Residue |
| Q94599572 | N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease |
| Q41849432 | Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells |
| Q38262594 | Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease |
| Q26996672 | Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy |
| Q41521563 | SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models |
| Q54980748 | Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors. |
| Q35961070 | Similarities in Gene Expression Profiles during In Vitro Aging of Primary Human Embryonic Lung and Foreskin Fibroblasts |
| Q64146866 | Sphingolipid biosynthesis in man and microbes |
| Q49950035 | Sphingolipid metabolism in cancer signalling and therapy |
| Q47374235 | Sphingolipids and their metabolism in physiology and disease |
| Q38809404 | Sphingolipids in mitochondria. |
| Q91713420 | Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target |
| Q30452205 | Sphingosine kinase activity is not required for tumor cell viability |
| Q38177794 | Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease |
| Q30276096 | Sphingosine kinase inhibitors: a review of patent literature (2006-2015). |
| Q42957279 | Sphingosine kinase: a closer look at last |
| Q38448843 | Sphingosine-1-phosphate metabolism: A structural perspective |
| Q27684680 | Structural Basis of Lipid Binding for the Membrane-embedded Tetraacyldisaccharide-1-phosphate 4'-Kinase LpxK |
| Q30276790 | Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles |
| Q30277138 | Structure-Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors |
| Q30360636 | Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors. |
| Q42851878 | Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors |
| Q51158846 | Structure-based functional annotation of hypothetical proteins from Candida dubliniensis: a quest for potential drug targets. |
| Q35131477 | Synthesis and biological evaluation of carbocyclic analogues of pachastrissamine |
| Q92158160 | Targeting sphingosine kinase 1 in acute myeloid leukemia: translation to clinic |
| Q34364844 | Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond |
| Q49571965 | The unmasking of the lipid binding face of sphingosine kinase 1. |
| Q89414557 | Theoretical models to predict the inhibitory effect of ligands of sphingosine kinase 1 using QTAIM calculations and hydrogen bond dynamic propensity analysis |
| Q38915115 | Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism |
| Q38909416 | Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. |
| Q64111780 | Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting |
| Q30252641 | Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity |
Search more.